연구동향 분석

일 대학병원 정신건강의학과 입원 환자의 체중 및 대사증후군의 변화

장우영(Woo-Young Jang) 이광헌(Kwang-Hun Lee) 배나리(Na-Ri Bae) 이성민(Sung-Min Lee) 김태우 ( Tae Woo Kim ) 사공정규(Jung-Kyu Sakong) 곽경필(Kyung-Phil Kwak) 2014년

논문상세정보
인용/피인용
' 일 대학병원 정신건강의학과 입원 환자의 체중 및 대사증후군의 변화' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • body weight
  • lipids
  • metabolic syndrome
  • psychotropicagents
  • 대사증후군
  • 정신작용제
  • 지질
  • 체중
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,427 1

0.0%

' 일 대학병원 정신건강의학과 입원 환자의 체중 및 대사증후군의 변화' 의 참고문헌

  • 항정신병약물을 처음으로 사용하는 초발 정신증 환자에서 나타나는 체중 및 대사성 지표의 변화 : 후향적 연구
    김우진 생물치료정신의학 17 (2) : 229 ~ 238 [2011]
  • 만성 정신분열병 환자들의 대사증후군과 관련된 임상 특징들
    남윤영 대한정신약물학회지 17 (4) : 335 ~ 341 [2006]
  • 대사증후군
    김미경 대한의사협회지 55 (10) : 1005 ~ 1013 [2012]
  • The metabolic syndrome:prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
    Park YW Arch Intern Med 163 : 427 ~ 436 [2003]
  • The metabolic syndrome and schizophrenia
    Meyer JM Acta Psychiatr Scand 119 : 4 ~ 14 [2009]
  • The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications
    McIntyre RS CNS Drugs 24 : 741 ~ 753 [2010]
  • Serious mental illness and mortality rates
    Berren MR Hosp Community Psychiatry 45 : 604 ~ 605 [1994]
  • Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective Study
    Murat Beyazyüz PSYCHIATRY INVESTIGATION 10 (2) : 148 ~ 154 [2013]
  • Psychotropic polypharmacy for the treatment of bipolar disorder in Taiwan
    Hung GC Psychiatr Serv 65 : 125 ~ 128 [2014]
  • Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S
    Ford ES Diabetes Care 28 : 2745 ~ 2749 [2005]
  • Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey
    Ford ES JAMA 287 : 356 ~ 359 [2002]
  • Prevalence of Metabolic Syndrome in Hispanic and Non-Hispanic Patients With Schizophrenia
    Kato MM Prim Care Companion J Clin Psychiatry 6 : 74 ~ 77 [2004]
  • Prevalence of Metabolic Syndrome in Chronic Schizophrenic Inpatients
    Kang KD J Korean Soc Biol Ther Psychiatry 18 : 281 ~ 289 [2012]
  • Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
    De Hert M World Psychiatry 10 : 52 ~ 77 [2011]
  • Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases
    Jin H Ann Clin Psychiatry 14 : 59 ~ 64 [2002]
  • Nutrition and exercise behavior among patients with bipolar disorder
    Kilbourne AM Bipolar Disord 9 : 443 ~ 452 [2007]
  • National trends in psychotropic medication polypharmacy in office-based psychiatry
    Mojtabai R Arch Gen Psychiatry 67 : 26 ~ 36 [2010]
  • Mortality and medical comorbidity among psychiatric patients: a review
    Felker B Psychiatr Serv 47 : 1356 ~ 1363 [1996]
  • Modal subcomponents of metabolic syndrome in patients with bipolar disorder
    Cardenas J J Affect Disord 106 : 91 ~ 97 [2008]
  • Metabolic syndrome in patients with schizophrenia and bipolar disorder: comparision with general population
    Lee NY Abstracted presented at the Korea Neuropsychiatric Association Annual Meeting [2008]
  • Metabolic syndrome in patients with schizophrenia
    Heiskanen T J Clin Psychiatry 64 : 575 ~ 579 [2003]
  • Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians
    Fagiolini A Bipolar Disord 7 : 424 ~ 430 [2005]
  • Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators
    Vancampfort D Am J Psychiatry 170 : 265 ~ 274 [2013]
  • Metabolic syndrome and depression: a cross-sectional analysis
    Heiskanen TH J Clin Psychiatry 67 : 1422 ~ 1427 [2006]
  • Metabolic side effects of antipsychotic medication
    Tschoner A Int J Clin Pract 61 : 1356 ~ 1370 [2007]
  • Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
    De Hert M Nat Rev Endocrinol 8 : 114 ~ 126 [2011]
  • Medical morbidity, mental illness, and substance use disorders
    Dickey B Psychiatr Serv 53 : 861 ~ 867 [2002]
  • Lifestyle approaches and dietary strategies to lower LDL-cholesterol and triglycerides and raise HDL-cholesterol
    Katcher HI Endocrinol Metab Clin North Am 38 : 45 ~ 78 [2009]
  • Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine
    Kemp DE J Affect Disord 148 : 84 ~ 91 [2013]
  • Insulin resistance - a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease
    DeFronzo RA Diabetes Care 14 : 173 ~ 194 [1991]
  • Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007
    Lim S Diabetes Care 34 : 1323 ~ 1328 [2011]
  • Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;International Atherosclerosis Society; and International Association for the Study of Obesity
    Alberti KG Circulation 120 : 1640 ~ 1645 [2009]
  • Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia
    Zhang ZJ Br J Psychiatry 184 : 58 ~ 62 [2004]
  • Drug-induced metabolic syndrome
    Wofford MR J Clin Hypertens (Greenwich) 8 : 114 ~ 119 [2006]
  • Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    Grundy SM Circulation 112 : 2735 ~ 2752 [2005]
  • Consensus development conference on antipsychotic drugs and obesity and diabetes
    American Diabetes Association Diabetes Care 27 : 596 ~ 601 [2004]
  • Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states
    Colton CW Prev Chronic Dis 3 : A42 ~ [2006]
  • Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo
    L’Italien GJ J Clin Psychiatry 68 : 1510 ~ 1516 [2007]
  • Clinically significant pharmacokinetic drug interactions with carbamazepine. An update
    Spina E Clin Pharmacokinet 31 : 198 ~ 214 [1996]
  • Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome
    Cohn T Can J Psychiatry 49 : 753 ~ 760 [2004]
  • Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1
    Meyer JM Schizophr Res 101 : 273 ~ 286 [2008]
  • Cardiovascular morbidity and mortality associated with the metabolic syndrome
    Isomaa B Diabetes Care 24 : 683 ~ 689 [2001]
  • Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment
    Steylen PM Int J Psychiatry Clin Pract 17 : 125 ~ 130 [2013]
  • Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
    Nasrallah HA Mol Psychiatry 13 : 27 ~ 35 [2008]
  • Appropriate waist circumference cutoff points for central obesity in Korean adults
    Lee SY Diabetes Res Clin Pract 75 : 72 ~ 80 [2007]
  • A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?
    Saha S Arch Gen Psychiatry 64 : 1123 ~ 1131 [2007]
  • A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)
    Stroup TS Am J Psychiatry 168 : 947 ~ 956 [2011]
  • A comparison of the prevalence of the MS and its complications using three proposed definitions in Korean subjects
    Sung KC Am J Cardiol 103 : 1732 ~ 1735 [2009]